Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models-Reference-Cited by-同舟云学术

Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models

Published:2019-04-15 Issue:10 Volume:202 Page:2888-2906
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Haselmayer Philipp^ORCID,Camps Montserrat,Liu-Bujalski Lesley,Nguyen Ngan,Morandi Federica,Head Jared,O’Mahony Alison,Zimmerli Simone C.,Bruns Lisa,Bender Andrew T.,Schroeder Patricia,Grenningloh Roland^ORCID

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference79 articles.

1. The Src, Syk, and Tec family kinases: Distinct types of molecular switches

2. The Role of Tec Family Kinases in Myeloid Cells

3. Signaling network of the Btk family kinases

4. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors

5. Brutonˈs tyrosine kinase-an integral protein of B cell development that also has an essential role in the innate immune system

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bruton’s tyrosine kinase: A promising target for treating systemic lupus erythematosus;International Immunopharmacology;2024-12

2. Comprehensive Characterization of BTK Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Non-covalent Mechanistic Signatures;2024-09-08

3. Targeting Bruton’s tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments;Advances in Rheumatology;2024-08-21

4. Biological Clock Perspective in Rheumatoid Arthritis;Inflammation;2024-08-10

5. Unraveling the Role of the Glycogen Synthase Kinase-3β, Bruton’s Tyrosine Kinase, and Sphingosine 1 Phosphate Pathways in Multiple Sclerosis;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-08